Jonathan Violin Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

VRDN Quotes by TradingView

Jonathan Violin is Chief Executive Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 430,905 shares of VRDN, which is worth approximately $8.53 Million. The most recent transaction as insider was on Feb 02, 2023, when has been sold 50,000 shares (Common Stock) at a price of $36.8 per share, resulting in proceeds of $1,839,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 431K
0% 3M change
0% 12M change
Total Value Held $8.53 Million

Jonathan Violin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2023
SELL
Open market or private sale
$1,839,999 $36.8 p/Share
50,000 Reduced 10.4%
430,905 Common Stock
Jun 01 2022
SELL
Open market or private sale
$366,000 $12.2 p/Share
30,000 Reduced 5.87%
480,905 Common Stock
May 02 2022
SELL
Open market or private sale
$391,200 $13.04 p/Share
30,000 Reduced 5.55%
510,905 Common Stock
Apr 04 2022
SELL
Open market or private sale
$68,148 $18.93 p/Share
3,600 Reduced 0.66%
540,905 Common Stock
Apr 01 2022
SELL
Open market or private sale
$499,488 $18.92 p/Share
26,400 Reduced 4.62%
544,505 Common Stock
Mar 02 2022
SELL
Open market or private sale
$192,800 $17.36 p/Share
11,106 Reduced 1.91%
570,905 Common Stock
Mar 01 2022
SELL
Open market or private sale
$336,691 $17.82 p/Share
18,894 Reduced 3.14%
582,011 Common Stock
Feb 03 2022
SELL
Open market or private sale
$17,416 $19.16 p/Share
909 Reduced 0.15%
600,905 Common Stock
Feb 02 2022
SELL
Open market or private sale
$227,920 $18.47 p/Share
12,340 Reduced 2.01%
601,814 Common Stock
Feb 01 2022
SELL
Open market or private sale
$327,482 $19.55 p/Share
16,751 Reduced 2.66%
614,154 Common Stock
Dec 08 2021
BUY
Conversion of derivative security
-
627,564 Added 49.87%
630,905 Common Stock
Oct 27 2020
BUY
Other acquisition or disposition
-
50,124 Added 50.0%
50,124 Common Stock

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
Director
MGTA
Magenta Therapeutics, Inc. Healthcare
JV

Jonathan Violin

Chief Executive Officer
Boulder, CO

Track Institutional and Insider Activities on VRDN

Follow Viridian Therapeutics, Inc.\DE and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

News

Receive news related to Viridian Therapeutics, Inc.\DE

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VRDN